Status:
COMPLETED
Chemotherapy and Radiotherapy for Osteolymphoma
Lead Sponsor:
Trans Tasman Radiation Oncology Group
Collaborating Sponsors:
Australasian Leukaemia and Lymphoma Group
Australasian Radiation Oncology Lymphoma Group
Conditions:
Osteolymphoma
Eligibility:
All Genders
17+ years
Phase:
NA
Brief Summary
This trial is intended to determine the results obtained when standard treatment for Non Hodgkin's lymphoma is applied to the disease in a rare subtype which arises in bone. Patients in the study unde...
Detailed Description
Patients with non-Hodgkin's lymphoma arising primarily in bone have been studied using a number of different names making literature searching difficult. The term Osteolymphoma has been proposed to ma...
Eligibility Criteria
Inclusion
- Histologically confirmed non-Hodgkin's lymphoma in a bony site
- Limited extraosseous disease
- Ann Arbor stage IE
- Age \>17
- ECOG performance status \<3
- Expected survival \> 6 months
- Patients capable of childbearing are using adequate contraception.
- Written informed consent
Exclusion
- Previous radiotherapy
- Previous malignancy
- Medically unfit to undergo treatment
Key Trial Info
Start Date :
September 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00141648
Start Date
September 1 2000
End Date
February 1 2008
Last Update
October 1 2009
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia, 2050
2
Liverpool Hospital
Liverpool, New South Wales, Australia, 1871
3
Calvary Mater Newcastle
Newcastle, New South Wales, Australia, 2310
4
Westmead Hospital
Wentworthville, New South Wales, Australia, 2145